Cho Youmin, Hwang Misun, Gong Yang, Jiang Yun
College of Nursing, Chungnam National University, Daejeon, South Korea.
School of Nursing, University of Michigan, Ann Arbor, MI, USA.
Eur J Oncol Nurs. 2025 Jun;76:102857. doi: 10.1016/j.ejon.2025.102857. Epub 2025 Mar 4.
PURPOSE: This study aimed to investigate perceived medication safety in patients with cancer during transitions of care and identify factors associated with their safety perceptions. METHODS: A secondary data analysis was performed on a cross-sectional survey data of from patients with four types of cancer (i.e., colorectal, lung, prostate, and breast). Perceived medication safety was measured by the sum score of four survey items that assessed patients' feelings about medication safety during transitions of care. Potential associated factors included sociodemographic and clinical factors (i.e., cancer types, taking oral anticancer agents), self-rated health, perceived safety in communicating with clinicians, beliefs about medications, and medication self-management ability. Descriptive statistics, bivariate correlations, and multiple linear regressions were performed. RESULTS: A total of 183 patients were included, with a mean (SD) age of 65.04 (11.07). Participants reported a moderate level of perceived medication safety (mean [SD] = 13.56 [1.85], median = 13, IQR: 12-15). Multiple linear regression analysis revealed that better medication self-management ability (coefficient = 0.29, p < .001), feeling safer in communication with healthcare providers (coefficient = 0.87, p < .001), and having less concern about medications (coefficient = -0.11, p < .001) were significantly associated with higher perceived medication safety. Additionally, younger age (coefficient = -0.03, p = .02) was associated with higher perceived medication safety. The final model explained 43% of the variance. CONCLUSIONS: The study's findings underscore the importance of effective communication and self-management in enhancing medication safety in patients with cancer during transitions of care, particularly for older adults needing additional support.
目的:本研究旨在调查癌症患者在护理转接期间对药物治疗安全性的认知,并确定与其安全认知相关的因素。 方法:对四种癌症(即结直肠癌、肺癌、前列腺癌和乳腺癌)患者的横断面调查数据进行二次数据分析。通过四个调查项目的总分来衡量对药物治疗安全性的认知,这些项目评估了患者在护理转接期间对药物治疗安全性的感受。潜在的相关因素包括社会人口统计学和临床因素(即癌症类型、服用口服抗癌药物)、自我健康评价、与临床医生沟通时的安全感、对药物的信念以及药物自我管理能力。进行了描述性统计、双变量相关性分析和多元线性回归分析。 结果:共纳入183名患者,平均(标准差)年龄为65.04(11.07)岁。参与者报告的药物治疗安全认知水平中等(平均[标准差]=13.56[1.85],中位数=13,四分位间距:12 - 15)。多元线性回归分析显示,更好的药物自我管理能力(系数=0.29,p<.001)、与医疗服务提供者沟通时感觉更安全(系数=0.87,p<.001)以及对药物的担忧较少(系数=-0.11,p<.001)与更高的药物治疗安全认知显著相关。此外,年龄较小(系数=-0.03,p=.02)与更高的药物治疗安全认知相关。最终模型解释了43%的方差。 结论:研究结果强调了有效沟通和自我管理在提高癌症患者护理转接期间药物治疗安全性方面的重要性,特别是对于需要额外支持的老年人。
Support Care Cancer. 2024-5-15
Support Care Cancer. 2019-1-28
Res Social Adm Pharm. 2024-2
BMJ Open Qual. 2023-5
Front Public Health. 2022